Bank of America
FOLD

Bank of America’s Amicus Therapeutics FOLD Stock Holding History

Bank of America’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,000
Closed -$418K – 8284
2022
Q3 		$418K Hold
40,000
– – ﹤0.01% 5535
2022
Q2 		$430K Buy
+40,000
New +$329K ﹤0.01% 5543
2019
Q4 		– Sell
-50,000
Closed -$401K – 7184
2019
Q3 		$401K Buy
+50,000
New +$543K ﹤0.01% 5228
2018
Q1 		– Sell
-20,000
Closed -$288K – 7174
2017
Q4 		$288K Buy
20,000
+9,500
+90% +$131K ﹤0.01% 5244
2017
Q3 		$158K Buy
+10,500
New +$139K ﹤0.01% 5488
2015
Q2 		– Sell
-30,000
Closed -$326K – 7312
2015
Q1 		$326K Buy
+30,000
New +$264K ﹤0.01% 4610

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America's FOLD Position: Q1 2026 in Review

Bank of America increased its Amicus Therapeutics (FOLD) stake by 13% in Q1 2026, buying an estimated $6.61M and bringing the position to 3,899,490 shares worth $56.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Bank of America first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Bank of America held 3,899,490 shares of Amicus Therapeutics worth $56.4M as of Q1 2026.
  • Bank of America bought 461,249 Amicus Therapeutics shares in Q1 2026, an estimated $6.61M.
  • Amicus Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1510 holding.
  • Bank of America first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.